Results 181 to 190 of about 13,918 (210)
Some of the next articles are maybe not open access.
International Journal of Radiation Oncology, Biology, Physics, 2023
PURPOSE/OBJECTIVE To determine the safety and tolerability of combining stereotactic ablative radiotherapy (SABR) and durvalumab with respect to rates of Grade ≥3 non-hematological toxicity in medically inoperable patients with early-stage non-small cell
Trudy C. Wu +19 more
semanticscholar +1 more source
PURPOSE/OBJECTIVE To determine the safety and tolerability of combining stereotactic ablative radiotherapy (SABR) and durvalumab with respect to rates of Grade ≥3 non-hematological toxicity in medically inoperable patients with early-stage non-small cell
Trudy C. Wu +19 more
semanticscholar +1 more source
Journal of Clinical Oncology, 2023
TPS4604 Background: The treatment for patients with metastatic RCC is evolving. The current standard of care for patients presenting with de novo metastatic disease is combination immunotherapy (IO)-based treatment.
W. Hall +14 more
semanticscholar +1 more source
TPS4604 Background: The treatment for patients with metastatic RCC is evolving. The current standard of care for patients presenting with de novo metastatic disease is combination immunotherapy (IO)-based treatment.
W. Hall +14 more
semanticscholar +1 more source
International Journal of Radiation Oncology, Biology, Physics
BACKGROUND While stereotactic ablative body radiotherapy (SABR) is associated with excellent local control for primary renal cell carcinoma (RCC), outcomes based on clear-cell (ccRCC) and non-clear cell (nccRCC) histologies are not well defined ...
Muhammad Ali +25 more
semanticscholar +1 more source
BACKGROUND While stereotactic ablative body radiotherapy (SABR) is associated with excellent local control for primary renal cell carcinoma (RCC), outcomes based on clear-cell (ccRCC) and non-clear cell (nccRCC) histologies are not well defined ...
Muhammad Ali +25 more
semanticscholar +1 more source
International Journal of Radiation Oncology, Biology, Physics
PURPOSE The Anonymized trial demonstrated the safety and efficacy of stereotactic ablative body radiotherapy (SABR) in patients with inoperable renal cell carcinoma (RCC).
Constanza Vargas +16 more
semanticscholar +1 more source
PURPOSE The Anonymized trial demonstrated the safety and efficacy of stereotactic ablative body radiotherapy (SABR) in patients with inoperable renal cell carcinoma (RCC).
Constanza Vargas +16 more
semanticscholar +1 more source
International Journal of Radiation Oncology, Biology, Physics, 2023
PURPOSE Stereotactic ablative radiotherapy (SABR) is increasingly used to treat renal cell carcinoma (RCC). However, the optimal method to assess treatment response is unclear. We aimed to quantify changes in both volume and maximum linear size of tumors
D. Schep +8 more
semanticscholar +1 more source
PURPOSE Stereotactic ablative radiotherapy (SABR) is increasingly used to treat renal cell carcinoma (RCC). However, the optimal method to assess treatment response is unclear. We aimed to quantify changes in both volume and maximum linear size of tumors
D. Schep +8 more
semanticscholar +1 more source
International Journal of Radiation Oncology, Biology, Physics
PURPOSE This phase 1 study aimed to assess the safety and feasibility of SABR delivery to all sites of polymetastatic disease (>10 metastases). METHODS AND MATERIALS A 3+3 study design was used with five dose levels from 6 Gy (6 Gy x 1) to 30 Gy (6 Gy ...
Timothy K. Nguyen +14 more
semanticscholar +1 more source
PURPOSE This phase 1 study aimed to assess the safety and feasibility of SABR delivery to all sites of polymetastatic disease (>10 metastases). METHODS AND MATERIALS A 3+3 study design was used with five dose levels from 6 Gy (6 Gy x 1) to 30 Gy (6 Gy ...
Timothy K. Nguyen +14 more
semanticscholar +1 more source
European Urology, 2018
BACKGROUND Stereotactic ablative body radiotherapy (SABR) is an emerging treatment option for oligometastatic prostate cancer. However, limited prospective evidence is available. OBJECTIVE To determine the safety and feasibility of single fraction SABR
Cristian Udovicich +2 more
exaly +2 more sources
BACKGROUND Stereotactic ablative body radiotherapy (SABR) is an emerging treatment option for oligometastatic prostate cancer. However, limited prospective evidence is available. OBJECTIVE To determine the safety and feasibility of single fraction SABR
Cristian Udovicich +2 more
exaly +2 more sources
International Journal of Radiation Oncology, Biology, Physics, 2022
PURPOSE Despite increasing utilization of stereotactic ablative therapy (SABR) for oligometastatic cancer, prospective outcomes are lacking. The purpose of this study was to determine progression-free survival (PFS), local control (LC) and prognostic ...
S. Baker +15 more
semanticscholar +1 more source
PURPOSE Despite increasing utilization of stereotactic ablative therapy (SABR) for oligometastatic cancer, prospective outcomes are lacking. The purpose of this study was to determine progression-free survival (PFS), local control (LC) and prognostic ...
S. Baker +15 more
semanticscholar +1 more source
International Journal of Radiation Oncology, Biology, Physics
PURPOSE The optimal sequencing of local and systemic therapy for oligometastatic cancer has not been established. This study retrospectively compared progression-free survival (PFS), overall survival (OS), and SABR-related toxicity between upfront versus
S. Baker +32 more
semanticscholar +1 more source
PURPOSE The optimal sequencing of local and systemic therapy for oligometastatic cancer has not been established. This study retrospectively compared progression-free survival (PFS), overall survival (OS), and SABR-related toxicity between upfront versus
S. Baker +32 more
semanticscholar +1 more source
Seminars in Thoracic and Cardiovascular Surgery
Stereotactic ablative radiotherapy (SABR) has emerged as an alternative, non-surgical treatment for high-risk patients with stage I non-small cell lung cancer (NSCLC) with increased use over time.
Andrea Wolf +23 more
semanticscholar +1 more source
Stereotactic ablative radiotherapy (SABR) has emerged as an alternative, non-surgical treatment for high-risk patients with stage I non-small cell lung cancer (NSCLC) with increased use over time.
Andrea Wolf +23 more
semanticscholar +1 more source

